Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and analgesic knee injection after hemiepiphysiodesis in children with genu varum or genu valgum
IRCT20260618069859N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of platelet-rich plasma, bupivacaine and ketorolac in Genu varum and Genu valgum (4 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Pain intensity. Started Jul 2026; status: completed.
02
Drugs
platelet-rich plasmabupivacaineketorolac
03
Conditions
Genu varumGenu valgum
Beyond the preview
Go deeper on IRCT20260618069859N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260618069859N1.